EANM Marie Curie Award

Who can apply?

  • Candidates must have their regular residence in Europe.
  • At least one of the authors must be a member of the EANM.
  • Only work which has been done in Europe can be considered.
  • The submitted paper must not have been published before the last EANM Congress; possible candidates are invited by the Congress Chair to provide testimony for this.
  • A certificate must be presented, showing that legal requirements (including ethical and radiation protection requirements) were met when performing the study.
  • The Award should be given to the author of the work which is, in terms of scientific quality, the best contribution at the annual EANM Congress.

The Award

  • Presenting their research during the Award Ceremony.
  • Marie Curie Medal and diploma handed over on stage during Award Ceremony by the EANM President
  • Award of € 5,000.-, will be transferred after the Congress.
  • One complimentary (& transferable) registration for the EANM Focus Meeting 4.

Application and Procedure

  • The best scored 2 abstracts from each abstract category fulfilling the MCA criteria, are selected. Those abstracts will be again blinded and rated by the EANM Scientific Programme Council.
  • The best 10 rated abstracts will be once more reviewed (blinded) by international peer reviewers.
  • The EANM office will notify the authors of the top 3 submissions, requesting a portrait picture, a 2-slides-presentation and their onsite presence at the Closing Ceremony.
  • The Award is bestowed during the Award Ceremony of the EANM Congress by the EANM President. The decision is not open to appeal or legal action.

 

 

 

For outstanding scientific work presented at the 32nd Annual Congress of the European Association of Nuclear Medicine the Marie Curie Fund of the EANM bestowed the Marie Curie Award to

Changes in synaptic density in relation to tau deposition in prodromal
Alzheimer’s disease: a dual protocol PET-MR study

H. R. J. Vanhaute1, J. Ceccarini2, L. Michiels3, S. Sunaert4, R. Lemmens3, L. Emsell4, M. Vandenbulcke5, K. Van Laere2;

1Nuclear Medicine and molecular imaging, Department of Geriatric Psychiatry, University Hospitals Leuven; department of imaging and pathology, Catholic University Leuven, Leuven, BELGIUM, 2Nuclear Medicine and molecular imaging, University Hospitals Leuven; department of imaging and pathology, Catholic University Leuven, Leuven, BELGIUM, 3Department of Neurology, University Hospitals Leuven; Laboratory for neurobiology, Catholic University Leuven; Center for Brain and disease research, VIB-KU Leuven, Leuven, BELGIUM, 4Department of Imaging and pathology, Translational MRI; Catholic University Leuven, Leuven, BELGIUM, 5Department of Geriatric Psychiatry, University Hospitals Leuven, Leuven, BELGIUM.